Trial Profile
Phase II trial of dornase alfa (PulmoXen) for the treatment of cystic fibrosis.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 Nov 2014
Price :
$35
*
At a glance
- Drugs Dornase alfa (Primary)
- Indications Cystic fibrosis
- Focus Adverse reactions; Therapeutic Use
- 26 Nov 2014 New trial record